Update/Specific Group Session |
Room 1 |
08:30-09:30 |
60min |
Update-1 Demyelinating+Peripheral |
김병준(성균관의대) |
조중양(인제의대) |
08:30-08:50 |
20min |
Demyelinating disease |
김수현(국립암센터) |
08:50-09:10 |
20min |
Neuromuscular disease |
신하영(연세의대) |
09:10-09:30 |
20min |
Autonomic disorder |
김현아(계명의대) |
Room 2 |
08:30-09:30 |
60min |
Specific Group Session 1 Dementia |
김범생(가톨릭의대 명예교수) |
한설희(건국의대) |
08:30-08:50 |
20min |
Amyloid pathology & imaging |
예병석(연세의대) |
08:50-09:10 |
20min |
Tau pathology & imaging |
노영(가천의대) |
09:10-09:30 |
20min |
Vascular pathology & imaging |
임재성(한림의대) |
Room 3 |
08:30-09:30 |
60min |
Specific Group Session 2 IOM |
서대원(성균관의대) |
박경석(서울의대) |
08:30-09:00 |
30min |
Clinical practice guideline for intraoperative neurophysiological monitoring: 2020 update |
김성민(서울의대) |
09:00-09:30 |
30min |
A.I analysis in intraoperative big data |
이형철(서울의대 마취통증의학과) |
Myung's Memorial Lecture |
Room1,2 |
09:35-10:30 |
55min |
Myung's Memorial Lecture |
박성호(서울의대) |
09:35-10:30 |
55min |
ALS의 진단과 치료: 도전과 과제 |
이광우 (서울의대 신경과 명예교수) |
Hot Issues in Neurogy |
Room3 |
09:35-10:30 |
55min |
Hot Issues in Neurology |
송홍기(한림의대) |
정기영(서울의대) |
09:35-09:53 |
18min |
COVID19 and Epilepsy |
문장섭(서울의대) |
09:53-10:11 |
18min |
COVID19 and Neuromuscular |
안석원(중앙의대) |
10:11-10:30 |
19min |
COVID19 and Sleep Medicine |
김근태(계명의대) |
Interactive Workshop/ Specific Group Session |
Room 1 |
10:40-12:10 |
90min |
Interactive Workshop 1 Updated Migraine Pathophysiology |
정진상(성균관의대) |
신동진(가천의대) |
10:40-11:10 |
30min |
Preventive treatment strategy in Migraine |
안진영(서울의료원) |
11:10-11:40 |
30min |
Triptans and CGRP monoclonal antibodies in Migraine |
김병건(을지의대) |
11:40-12:10 |
30min |
Botox in Migraine |
문희수(성균관의대) |
Room 2 |
10:40-12:10 |
90min |
Specific Group Session 3 Embolic Stroke |
윤병우(서울의대) |
나정호(인하의대) |
10:40-11:00 |
20min |
Afib registry in Korea |
서우근(성균관의대) |
11:00-11:20 |
20min |
Practical use of NOAC in neurology practice |
최재철(제주의대) |
11:20-11:40 |
20min |
Implantable loop recorder in ESUS |
임우현 (서울의대 순환기내과) |
11:40-12:00 |
20min |
PFO closure following cryptogenic stroke |
김범준(울산의대) |
12:00-12:10 |
10min |
Q & A |
|
Room 3 |
10:40-12:10 |
90min |
Specific Group Session 4 Consultant Neurology - Neuromuscular Disorders |
성정준(서울의대) |
배종석(한림의대) |
10:40-11:10 |
30min |
Paresthesia and weakness (I): chemotherapy or immune-checkpoint inhibitors |
손은희(충남의대) |
11:10-11:40 |
30min |
Paresthesia and weakness (II): iatrogenic or nutritional deficiencies |
김지은(이화의대) |
11:40-12:10 |
30min |
Perioperative evaluation and management of the patients with neuromuscular disorders |
백설희(고려의대) |
Interactive Workshop/ Specific Group Session |
Room 1 |
13:00-14:30 |
90min |
Interactive Workshop 2 Neurointervention |
이준(영남의대) |
서우근(성균관의대) |
13:00-13:30 |
30min |
When does TFCA dominate non-invasive vascular imaging? |
박희권(인하의대) |
13:30-14:00 |
30min |
How are we going to evaluate cerebral arterial anomalies with TFCA? |
정승욱(경상의대) |
14:00-14:30 |
30min |
Intracranial stenting: Is there any change after the WEAVE? |
정근화(서울의대) |
Room 2 |
13:00-14:30 |
90min |
Scientific Session 1 Dementia/Movement
|
이필휴(연세의대) |
서상원(성균관의대) |
13:00-13:13 |
13min |
Comparison of cilostazol and aspirin on changes in volume of cerebral small vessel disease white matter changes (CHALLENGE): a multicenter, randomized controlled trial |
최성혜(인하의대) |
13:13-13:26 |
13min |
Analyses of speech with a mobile application for the assessment of mild cognitive impairment and Alzheimer disease |
김우준(가톨릭의대) |
13:26-13:39 |
13min |
Functional brain network characteristics in patients with delayed cognitive decline after stroke |
임재성(한림의대) |
13:39-13:52 |
13min |
Long-term exposure to air pollution and risk of Parkinson’s disease: A population-based cohort study |
조성양(울산의대) |
13:52-14:05 |
13min |
Quantitative gait analysis using a pose-estimation algorithm with 2D-video of PD patients |
신정환(서울의대) |
14:05-14:18 |
13min |
The association of plasma neurofilament light chain with early Parkinson’s disease and isolated RBD |
박동규(아주의대) |
14:18-14:30 |
12min |
Factors associated with anticholinergic-induced oromandibular dyskinesia in patients with Parkinson’s disease |
하준영(연세의대) |
Room 3 |
13:00-14:30 |
90min |
Specific Group Session 5 Epilepsy 특수한 상황에서 항뇌전증약 선택하기 |
이병인(인제의대) |
김주한 (굿슬립신경과의원) |
13:00-13:30 |
30min |
임산부에서 뇌전증의 약물 치료법 |
배은기(인하의대) |
13:30-14:00 |
30min |
노인에서 뇌전증의 약물 치료법 |
김동욱(건국의대) |
14:00-14:30 |
30min |
급성증상발작의 정의 및 치료법 |
김정빈(고려의대) |
Interactive Workshop/ Scientific Session/ Specific Group Session |
Room 1 |
14:50-16:20 |
90min |
Interactive Workshop 3 치매와 먹는다는 것: You are what you eat -How the food you eat affects your brain |
한설희(건국의대) |
이병철(한림의대) |
14:50-15:20 |
30min |
언제, 얼마나 먹을까? |
안성기 (서울센트럴요양병원) |
15:20-15:50 |
30min |
무엇을 먹을까? |
이창선(광교참좋은병원) |
15:50-16:20 |
30min |
무엇을 먹지 말아야 할까? |
오지영(건국의대) |
Room 2 |
14:50-16:20 |
90min |
Scientific Session 2 Peripheral |
권기한(한림의대) |
최영철(연세의대) |
14:50-15:05 |
15min |
MOG-IgG in the CSF: Clinical implication of testing and its intrathecal synthesis |
권영남(가톨릭의대) |
15:05-15:20 |
15min |
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseases |
현재원(국립암센터) |
15:20-15:35 |
15min |
Serum biomarkers in double seronegative neuromyelitis optica spectrum disorder |
김혜원(울산의대) |
15:35-15:50 |
15min |
The importance of RNST on ocular onset MG : Useful predictive factor for conversion to generalized MG |
김기훈(연세의대) |
15:50-16:05 |
15min |
Cerebrospinal cytokine as diagnostic and prognostic biomarkers of Guillain-Barré syndrome |
김지은(이화의대) |
16:05-16:20 |
15min |
Suicide attempt in patients with amyotrophic lateral sclerosis: A population-based study using the NHIS database |
최석진(인하의대) |
Room 3 |
14:50-16:20 |
90min |
Specific Group Session 6 Neuro-ophthalmology Always Walks with You, Neurologist : Eye Movements in Neurological Disorders |
이형(계명의대) |
김지수(서울의대) |
14:50-15:10 |
20min |
Eye movements in stroke |
이승한(전남의대) |
15:10-15:30 |
20min |
Eye movements in peripheral disorders |
박지윤(울산의대) |
15:30-15:50 |
20min |
Eye movements in dementia |
이익성(순천향의대) |
15:50-16:10 |
20min |
Eye movements in parkinsonism |
최서영(부산의대) |
16:10-16:20 |
10min |
Q & A |
|